On February 24, 2026, the U.S. Food and Drug Administration (FDA) announced the introduction of new standards for its Produce Regulatory Program Standards (PRPS). This initiative,...
On February 17, 2026, California introduced Assembly Bill 2034 (AB 2034), a significant legislative effort aimed at enhancing the safety of food ingredients classified as generally...
The U.S. Food and Drug Administration (FDA) has announced a recall of the dietary supplement Vitality Plus, citing significant health risks that could lead to life-threatening...
A recent study indicates that drugs approved under the U.S. Food and Drug Administration’s (FDA) Breakthrough Therapy Designation may carry heightened safety risks. Research conducted by...
Enveda Biosciences, based in Boulder, has received approval from the U.S. Food and Drug Administration (FDA) to initiate clinical trials for its drug candidate, ENV-6946, aimed...
Pentixapharm Holding AG has received encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding its planned Phase 3 PANDA study. The formal written minutes...
Boulder-based Enveda Biosciences has received clearance from the U.S. Food and Drug Administration (FDA) to initiate clinical trials for its drug candidate, ENV-6946, aimed at treating...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) experienced a significant surge of 22.12% in after-hours trading on Tuesday, closing at $1.27. This increase follows the company’s fiscal year 2025...
Cytokinetics has achieved a significant milestone by securing its first drug approval from the U.S. Food and Drug Administration (FDA). The FDA granted clearance on January...
The U.S. Food and Drug Administration (FDA) has issued a critical warning to major retailers, including Target and Walmart, after discovering that recalled ByHeart infant formula...
